مكتبة

Item request has been placed!

Item request cannot be made.

Processing Request

Academic Journal

Efficacy and safety of moderate-intensity rosuvastatin plus ezetimibe versus high-intensity rosuvastatin monotherapy in the treatment of composite cardiovascular events with hypercholesterolemia: A meta-analysis.

Authors : Liu L; Department of Medical Protection Center, The 926th Hospital of Joint Logistics Support Force of Chinese People's Liberation Army, Kaiyuan, Yunan, China.; Deng Y

Subjects: Cardiovascular Diseases*/Cardiovascular Diseases*/Cardiovascular Diseases*/etiology ; Cardiovascular Diseases*/Cardiovascular Diseases*/Cardiovascular Diseases*/drug therapy ; Drug Therapy, Combination*

Source: PloS one [PLoS One] 2024 Nov 13; Vol. 19 (11), pp. e0310696. Date of Electronic Publication: 2024 Nov 13 (Print Publication: 2024).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Rosuvastatin attenuates airway inflammation and remodeling in a chronic allergic asthma model through modulation of the AMPKα signaling pathway.

Authors : Zhang L; Department of Respiratory Medicine, The First Affiliated Hospital of Hainan Medical University & Hainan Province Clinical Medical Center of Respiratory Disease, Haikou, China.; Huang FY

Subjects: Asthma*/Asthma*/Asthma*/drug therapy ; Asthma*/Asthma*/Asthma*/metabolism ; Asthma*/Asthma*/Asthma*/pathology

Source: PloS one [PLoS One] 2024 Jun 24; Vol. 19 (6), pp. e0305863. Date of Electronic Publication: 2024 Jun 24 (Print Publication: 2024).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Design, development, and characterization of amorphous rosuvastatin calcium tablets.

Authors : González, Rocío¹ (AUTHOR); Peña, Mª Ángeles¹ (AUTHOR) ; Torres, Norma Sofía¹ (AUTHOR)

Subjects: *ROSUVASTATIN; *DRUG solubility; *EXCIPIENTS

Source: PLoS ONE. 3/21/2022, Vol. 17 Issue 3, p1-23. 23p.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Rosuvastatin calcium nanoparticles: Improving bioavailability by formulation and stabilization codesign.

Authors : Alshora DH; Kayyali chair for Pharmaceutical Industries, Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.; Ibrahim MA

Subjects: Drug Compounding* ; Drug Design*; Anticholesteremic Agents/Anticholesteremic Agents/Anticholesteremic Agents/*pharmacokinetics

Source: PloS one [PLoS One] 2018 Jul 09; Vol. 13 (7), pp. e0200218. Date of Electronic Publication: 2018 Jul 09 (Print Publication: 2018).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

The prognosis of lipid reprogramming with the HMG-CoA reductase inhibitor, rosuvastatin, in castrated Egyptian prostate cancer patients: Randomized trial.

Authors : Karkeet RM; Pharmacology and Experimental Oncology Unit, Cancer Biology Department, National Cancer Institute, Cairo University, Cairo, Egypt.; Zekri AN

Subjects: Hydroxymethylglutaryl-CoA Reductase Inhibitors*/Hydroxymethylglutaryl-CoA Reductase Inhibitors*/Hydroxymethylglutaryl-CoA Reductase Inhibitors*/therapeutic use ; Prostatic Neoplasms*/Prostatic Neoplasms*/Prostatic Neoplasms*/drug therapy ; Prostatic Neoplasms*/Prostatic Neoplasms*/Prostatic Neoplasms*/surgery

Source: PloS one [PLoS One] 2022 Dec 08; Vol. 17 (12), pp. e0278282. Date of Electronic Publication: 2022 Dec 08 (Print Publication: 2022).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Development of β-cyclodextrin/polyvinypyrrolidone-co-poly (2-acrylamide-2-methylpropane sulphonic acid) hybrid nanogels as nano-drug delivery carriers to enhance the solubility of Rosuvastatin: An in vitro and in vivo evaluation.

Authors : Shoukat H; Faculty of pharmacy, Department of Pharmaceutics, The Islamia University of Bahawalpur, Bahawalpur, Pakistan.; Pervaiz F

Subjects: Drug Carriers*/Drug Carriers*/Drug Carriers*/chemistry ; Drug Carriers*/Drug Carriers*/Drug Carriers*/pharmacokinetics ; Drug Carriers*/Drug Carriers*/Drug Carriers*/pharmacology

Source: PloS one [PLoS One] 2022 Jan 21; Vol. 17 (1), pp. e0263026. Date of Electronic Publication: 2022 Jan 21 (Print Publication: 2022).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Rosuvastatin revert memory impairment and anxiogenic-like effect in mice infected with the chronic ME-49 strain of Toxoplasma gondii.

Authors : Evangelista FF; Health Sciences Department, State University of Maringá (UEM), Maringá, PR, Brazil.; Costa-Ferreira W

Subjects: Anxiety/Anxiety/Anxiety/*drug therapy ; Memory/Memory/Memory/*drug effects ; Memory Disorders/Memory Disorders/Memory Disorders/*drug therapy

Source: PloS one [PLoS One] 2021 Apr 15; Vol. 16 (4), pp. e0250079. Date of Electronic Publication: 2021 Apr 15 (Print Publication: 2021).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Synergistic protective effects of a statin and an angiotensin receptor blocker for initiation and progression of atherosclerosis.

Authors : Lee SG; Cardiovascular Research Institute, Yonsei University College of Medicine, Seoul, Korea.; Severance Integrative Research Institute for Cerebral and Cardiovascular Diseases, Yonsei University Health System, Seoul, Korea.

Subjects: Angiotensin Receptor Antagonists/Angiotensin Receptor Antagonists/Angiotensin Receptor Antagonists/*administration & dosage ; Atherosclerosis/Atherosclerosis/Atherosclerosis/*drug therapy ; Imidazoles/Imidazoles/Imidazoles/*administration & dosage

Source: PloS one [PLoS One] 2019 May 03; Vol. 14 (5), pp. e0215604. Date of Electronic Publication: 2019 May 03 (Print Publication: 2019).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Effect of high-dose rosuvastatin loading before percutaneous coronary intervention in Chinese patients with acute coronary syndrome: A systematic review and meta-analysis.

Authors : Ye Z; Department of Cardiology, the First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China.; Lu H

Subjects: Percutaneous Coronary Intervention*/Percutaneous Coronary Intervention*/Percutaneous Coronary Intervention*/methods; Acute Coronary Syndrome/Acute Coronary Syndrome/Acute Coronary Syndrome/*drug therapy ; Acute Coronary Syndrome/Acute Coronary Syndrome/Acute Coronary Syndrome/*surgery

Source: PloS one [PLoS One] 2017 Feb 23; Vol. 12 (2), pp. e0171682. Date of Electronic Publication: 2017 Feb 23 (Print Publication: 2017).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Beneficial Effects of Sarpogrelate and Rosuvastatin in High Fat Diet/Streptozotocin-Induced Nephropathy in Mice.

Authors : Kim DH; College of pharmacy, The Catholic University of Korea, Bucheon, Gyeonggi-do, 420-743, Republic of Korea.; Choi BH

Subjects: Diet, High-Fat/Diet, High-Fat/Diet, High-Fat/*adverse effects ; Renal Insufficiency, Chronic/Renal Insufficiency, Chronic/Renal Insufficiency, Chronic/*chemically induced ; Renal Insufficiency, Chronic/Renal Insufficiency, Chronic/Renal Insufficiency, Chronic/*drug therapy

Source: PloS one [PLoS One] 2016 Apr 20; Vol. 11 (4), pp. e0153965. Date of Electronic Publication: 2016 Apr 20 (Print Publication: 2016).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

نتائج البحث

فلترة النتائج

Efficacy and safety of moderate-intensity rosuvastatin plus ezetimibe versus high-intensity rosuvastatin monotherapy in the treatment of composite cardiovascular events with hypercholesterolemia: A meta-analysis.

Rosuvastatin attenuates airway inflammation and remodeling in a chronic allergic asthma model through modulation of the AMPKα signaling pathway.

Design, development, and characterization of amorphous rosuvastatin calcium tablets.

Rosuvastatin calcium nanoparticles: Improving bioavailability by formulation and stabilization codesign.

The prognosis of lipid reprogramming with the HMG-CoA reductase inhibitor, rosuvastatin, in castrated Egyptian prostate cancer patients: Randomized trial.

Development of β-cyclodextrin/polyvinypyrrolidone-co-poly (2-acrylamide-2-methylpropane sulphonic acid) hybrid nanogels as nano-drug delivery carriers to enhance the solubility of Rosuvastatin: An in vitro and in vivo evaluation.

Rosuvastatin revert memory impairment and anxiogenic-like effect in mice infected with the chronic ME-49 strain of Toxoplasma gondii.

Synergistic protective effects of a statin and an angiotensin receptor blocker for initiation and progression of atherosclerosis.

Effect of high-dose rosuvastatin loading before percutaneous coronary intervention in Chinese patients with acute coronary syndrome: A systematic review and meta-analysis.

Beneficial Effects of Sarpogrelate and Rosuvastatin in High Fat Diet/Streptozotocin-Induced Nephropathy in Mice.

اتصل بنا

اتبع